The global market for Bone and Joint Health Supplements is projected to reach US$14.3 billion by 2024, driven by growing aging population and increasing incidence of Osteoporosis, which in turn increases the risks of fractures. Unhealthy food and sedentary lifestyle, coupled with lack of physical exercise giving rise to bone and joint health problems, are the other factors driving market growth.
Aging population and increasing incidence of Osteoporosis, which in turn leads to bone and joint fractures, is driving the bone and joint health supplements market across the globe. Besides osteoporosis, increasing intake of unhealthy food, and sedentary lifestyle, coupled with lack of physical exercise, is also giving rise to bone and joint health problems, driving the market for bone and joint health supplements. The global bone and joint health supplements market is witnessing growth due to a shift towards proactive approach of treating diseases. Consumers are now focusing more on preventing diseases rather than on treating them. Moreover, nutritionists and healthcare experts are conducting various awareness programs for preventing bone-related disorders and diseases.
Glucosamine-Chondroitin and Calcium supplements represent the largest product segments of Bone and Joint Health Supplements accounting for a major lion's share of the global sales. The global market has witnessed an increase in the popularity of calcium-fortified beverages and foods as well calcium supplements. The Other Supplements category (including vitamin D, vitamin K2, MSM, soy isoflavones, collagen, Peptides among others) represents the fastest growing bone & joint health supplements market over the ensuing years.
Functional/fortified foods and beverages are slowly gaining traction in the bone and joint health supplement market. While protein bars filled with active ingredients has been witnessing increased sales, powdered and liquid beverages fortified with magnesium and calcium has been witnessing growth. Besides middle-aged consumers wanting to maintain an active lifestyle, consumers fitting into the fitness and athletic demographics profile form a major chunk of bone and joint supplements market. As such, sports performance category offers a huge growth potential for bone and joint supplements
The US constitutes the largest regional market for Bone and Joint Health Supplements. Low bone mass affects more than 40 million individuals in the U.S. Post-menopausal women are the most vulnerable group for osteoporosis due to estrogen loss and low level of exercise. Besides women, aging population (65+ and above) also constitutes a group prone to develop Osteoarthritis. The condition also affects several younger people who exercise to a significant extent. Asia-Pacific, however, is poised to register the fastest growth at a CAGR of 7.6% over the analysis period. The major drivers for this growth are increasing incidence of arthritis globally along with growing obese population. Moreover, a shift towards sedentary lifestyle in developing markets is further expected to increase the demand for glucosamine-chondroitin.
Major players in the market include Archer Daniel Midland Company, BASF SE, Bergstrom Nutrition Inc., BioScience Nutrition, Cargill Inc., ESM Technologies LLC, Ethical Naturals Inc., Golden-Shell Biochemical Co. Ltd , Innophos Nutrition, Kappa Bioscience AS, Koninklijke DSM N.V., Nature's Bounty Inc., Navamedic ASA, Nutramax Laboratories Inc., NUTRILITE, Schiff Nutrition International Inc., and Simply Supplements, among others.